SITC Archive Library

SITC 30th Anniversary Annual Meeting (2015): Presidential Session
November 6-8, 2015
Gaylord National Hotel & Convention Center National Harbor, MD

Session Chair
Howard L. Kaufman, MD, FACS – Rutgers Cancer Institute of New Jersey

SITC 30th Anniversary Annual Meeting Organizers
Sandra Demaria, MD – Weill Cornell Medical College
Madhav Dhodapkar, MD – Yale University
Pamela S. Ohashi, PhD – Princess Margaret Cancer Centre
Jennifer A. Wargo, MD – University of Texas MD Anderson Cancer Center
Andrew D. Weinberg, PhD – Earle A. Chiles Research Institute

Program Summary
The Presidential Travel Award recipients' abstracts were the top scoring among those submitted for the the SITC 30th Anniversary Annual Meeting by young investigators, based on quality of research, excellence in results and methods, and the potential of their work to advance the field. Of the four Presidential Travel Award recipients, David Clever was selected to receive the Presidential Award based on his presentation during the Presidential Session on Saturday, November 7, 2015 in National Harbor, MD. Established in 1991, the SITC Presidential Award is the most prestigious Young Investigator Award and recognizes the young investigator deemed to have the most outstanding oral abstract presentation among those delivered in the Presidential Session of the SITC Annual Meeting.

About the SITC 30th Anniversary Annual Meeting
SITC's 30th Anniversary Annual Meeting provided a multidisciplinary educational and interactive environment focused on improving the outcome for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy research. The meeting consisted of cutting-edge research presentations by experts in the field, oral and poster abstract presentations and ample opportunity for both structured and informal discussions including important networking opportunities. In addition, the meeting included updates on major national and international initiatives coming from academia, government and industry, as well as ongoing SITC projects.

Target Audience
The target audience for this program included basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, researchers, graduate students, post-doctoral fellows, and allied health professionals involved in cancer research as well as pharmacists and payers that wished to learn more about cancer immunology and immunotherapy and its incorporation into current (and future) effective cancer treatment.

#2015#AnnualMeeting #Melanoma #PresentationSlides #SITC
#AdoptiveCellTherapy #CombinationTherapy #Clinician #Industry #Oncologist #Researcher